Can I Take Green Tea Extract (EGCG) With Trazodone?

What the interaction actually is, and why it matters for women

The short answer: combining high-dose green tea extract with trazodone is not automatically dangerous, but it is not automatically fine either. Two distinct biological mechanisms overlap here, and women face some hormone-related nuances that standard drug-information sources skip.

The first mechanism is pharmacokinetic. Trazodone is metabolized primarily by CYP3A4, a liver enzyme that also handles a long list of other drugs. Green tea's main bioactive compound, epigallocatechin gallate (EGCG), has been shown in in-vitro and some in-vivo studies to inhibit CYP3A4 activity. If CYP3A4 is slowed, trazodone clearance may fall, which means blood levels could rise higher than intended. A 2020 review in Drug Metabolism and Pharmacokinetics confirmed EGCG's inhibitory effect on several CYP isoforms, including CYP3A4, though most data come from cell-based models rather than clinical pharmacokinetic trials in humans.

The second mechanism is additive organ stress. Both trazodone and high-dose EGCG supplements carry independent signals for hepatotoxicity. The FDA has received reports of liver injury associated with concentrated EGCG supplements, and trazodone itself appears in case reports of drug-induced liver injury, though the absolute risk is low. Combining two hepatotoxic inputs does not simply double the risk, but it adds an unpredictable load.

Why "green tea" and "green tea extract" are not the same

A standard cup of brewed green tea contains roughly 50-100 mg of EGCG. A commercially sold green tea extract capsule often contains 400-800 mg of EGCG per serving, sometimes more. The European Food Safety Authority (EFSA) concluded in 2018 that EGCG intakes above 800 mg per day from supplements are associated with liver injury signals, while intake from tea beverages showed no such pattern. That dose gap is the core reason this distinction matters clinically.

What the pharmacokinetic data actually shows

Clinical pharmacokinetic trials specifically studying trazodone plus EGCG in humans do not yet exist. The interaction concern is inferred from two streams of evidence: known CYP3A4 involvement in trazodone metabolism and documented CYP3A4 inhibition by EGCG. A 2004 study published in Drug Metabolism and Disposition found that green tea polyphenols inhibited CYP3A4 in human liver microsomes in a concentration-dependent way. Concentrations sufficient to inhibit the enzyme in that model correspond to capsule-level doses, not beverage-level doses. This is an extrapolated concern, not a confirmed clinical interaction, and that honest limitation matters when you weigh your options.

Sex-specific physiology: how being a woman changes this picture

Hormonal fluctuations alter CYP3A4 activity

CYP3A4 is not static. Estrogen and progesterone both modulate its expression. During the luteal phase of your cycle, progesterone rises and CYP3A4 activity may shift, altering how quickly trazodone is processed. During perimenopause, estrogen fluctuates widely day to day. Oral contraceptives containing ethinyl estradiol are known CYP3A4 inducers, which means women on the pill may clear trazodone faster than baseline, partially offsetting any CYP3A4 inhibition from EGCG. Women not on hormonal contraception do not have that buffer. The net clinical implication is that the same EGCG capsule dose may have a different effect on trazodone levels depending on where you are in your cycle or your hormonal life stage, a nuance absent from most general drug-interaction resources.

Perimenopause: the life stage where this pair is most common

Trazodone is prescribed off-label for sleep disruption, which is one of the most common perimenopause symptoms. At the same time, perimenopausal women are frequent buyers of green tea extract, marketed for weight management, antioxidant support, and metabolic health. Up to 60 percent of perimenopausal women report significant sleep disturbance, and many reach for both pharmaceutical and supplement-based solutions simultaneously. If you are in perimenopause, taking trazodone for sleep, and adding an EGCG capsule for weight management, you are in the highest-likelihood group to be running both at once, and the one most likely to be overlooked in a 15-minute clinic visit.

Reproductive years and PCOS

Women with polycystic ovary syndrome (PCOS) represent another group where this combination may appear. EGCG has been studied for insulin sensitization in PCOS, and some women with PCOS and comorbid depression or anxiety may be on trazodone. A small randomized trial published in the Journal of the American College of Nutrition found green tea supplementation improved insulin sensitivity and reduced free testosterone in women with PCOS, which supports interest in EGCG in this population. Women with PCOS who are on trazodone should specifically flag the EGCG supplement to their provider rather than assuming it is just a "natural" product.

Pregnancy, lactation, and contraception

This section is required reading if there is any chance you are or could become pregnant.

Trazodone in pregnancy

Trazodone is classified as FDA Pregnancy Category C, meaning animal studies have shown adverse fetal effects and there are no adequate, well-controlled studies in pregnant women. Trazodone does cross the placenta. The available human data are sparse. A 2017 cohort study in BJOG included trazodone among antidepressants with limited safety data in pregnancy, and clinicians generally weigh the risk of untreated depression against fetal exposure individually. Trazodone is not a first-line antidepressant in pregnancy, but it is sometimes continued when other options have failed or when sleep disruption poses its own risk to the pregnancy.

Trazodone is not a known teratogen in the way that some other drugs are, but "Category C" means you cannot assume it is safe. If you are trying to conceive, talk with your OB-GYN or psychiatrist before continuing trazodone.

Green tea extract in pregnancy

High-dose EGCG supplements are not studied in human pregnancy. EGCG has shown anti-folate properties in animal models, and folate is critical for neural tube development, particularly in the first four weeks after conception, often before a woman knows she is pregnant. This mechanism alone makes concentrated EGCG supplements a supplement to avoid during pregnancy and when trying to conceive. Brewed green tea in moderate amounts (one to two cups per day) is generally considered acceptable during pregnancy, largely because the caffeine and EGCG concentrations are far lower.

Lactation

Trazodone transfers into breast milk in small amounts. A study in the British Journal of Clinical Pharmacology measured trazodone and its active metabolite in breast milk, with relative infant doses estimated to be low, though "low" does not mean zero exposure. The clinical decision to continue trazodone while breastfeeding should involve a lactation-informed clinician.

EGCG transfer into breast milk is not well characterized. Given the lack of safety data, high-dose EGCG supplements are best avoided during breastfeeding. The caffeine in green tea concentrate may also affect infant sleep if the mother is breastfeeding.

Contraception

Trazodone is not a teratogen that requires mandatory contraception the way that isotretinoin or valproate do. Still, because the drug carries Category C pregnancy risk, reliable contraception is advisable if you are sexually active and not trying to conceive, particularly since trazodone may be used long-term for sleep.

Liver health: the shared risk neither package insert mentions together

Both trazodone and high-dose EGCG supplements carry independent hepatotoxicity signals, but the combined picture is not widely discussed. Here is a practical framework for thinking about your cumulative liver burden:

Low concern:

• Trazodone at standard doses with 1-4 cups of brewed green tea per day
• No alcohol use, no other hepatotoxic supplements, normal liver function tests

Moderate concern:

• Trazodone at standard doses plus EGCG capsules at 200-400 mg per day
• Should be disclosed to your prescriber; liver enzymes worth monitoring annually

Higher concern:

• Trazodone plus EGCG capsules above 400 mg per day
• Any alcohol use added to the above
• Pre-existing elevated AST or ALT
• Other hepatotoxic supplements concurrently (kava, high-dose niacin, acetaminophen above 2 g/day)

The Drug-Induced Liver Injury Network (DILIN), a multicenter NIH-funded consortium, has catalogued both herbal/dietary supplement-induced and drug-induced liver injury. Their data show that dietary supplements now account for approximately 20 percent of drug-induced liver injury cases in the United States, up from 7 percent a decade earlier. Green tea extract is among the named implicated supplements.

Symptoms of liver stress to watch for: upper right abdominal discomfort, unexplained fatigue, yellowing of the skin or eyes, dark urine, or nausea that does not resolve. If you notice any of these while taking both, stop the EGCG supplement and contact your provider the same day.

Who this combination is appropriate for, and who should stop first

Likely fine to continue

• You drink 1-3 cups of brewed green tea daily and take trazodone at a standard dose
• Your liver enzymes have been checked in the past year and are normal
• You are not pregnant, not trying to conceive, and not in the first trimester
• You do not drink alcohol regularly

Talk to your provider before continuing

• You take EGCG in capsule form at any dose
• You have elevated liver enzymes, a history of liver disease, or hepatitis B or C
• You are perimenopausal and using trazodone for sleep, with EGCG for weight or metabolic support
• You have PCOS and take both
• You take other CYP3A4-affecting drugs: certain antibiotics (clarithromycin), antifungals (fluconazole), HIV medications, or grapefruit regularly

Stop the EGCG supplement until further guidance if

• You are pregnant or trying to conceive
• You are breastfeeding and taking doses above beverage levels
• You have jaundice, dark urine, or unexplained right-sided abdominal pain
• Your provider has found elevated transaminases (AST or ALT more than twice the upper limit of normal)

Monitoring and what to do if you are already taking both

If you are already taking trazodone and a green tea extract supplement and nothing has gone wrong, that is actually the most common outcome. The interaction is a signal, not a certainty. Here is what to do now.

Tell your prescriber at your next visit

Name the supplement, the dose per capsule, and how many capsules per day. Many prescribers are not aware of the EGCG-CYP3A4 data, and pharmacists are often the best resource for a quick interaction screen.

Request a liver function panel if you have not had one

A basic metabolic panel or a liver function panel (AST, ALT, bilirubin, alkaline phosphatase) gives your provider a baseline. The American College of Gastroenterology does not mandate routine monitoring for trazodone use alone, but adding a high-dose hepatotoxic supplement changes the clinical picture.

Dose-separate if you continue both

There is no established dose-separation window for EGCG and trazodone the way there is for some mineral-drug pairs. The CYP3A4 inhibition from EGCG is not primarily an absorption-window issue. It reflects enzyme induction kinetics that persist for hours after ingestion. Timing them apart by a few hours does not eliminate the pharmacokinetic concern but may modestly reduce peak plasma overlap. Taking trazodone at night and EGCG in the morning is a pragmatic choice while a more definitive conversation with your provider happens.

Watch for signs of elevated trazodone levels

If CYP3A4 is genuinely inhibited and trazodone levels rise, you might notice more sedation than usual, dizziness when standing (orthostatic hypotension), a slower or irregular heartbeat, or more pronounced dry mouth. These are trazodone side effects at normal doses that may intensify if levels creep up. Report them.

What the evidence gaps mean for you

Women have been historically underrepresented in pharmacokinetic drug trials, and supplement-drug interaction research is even thinner. The specific combination of EGCG and trazodone has not been studied in a clinical trial. What exists is:

• In-vitro and microsomal data on EGCG and CYP3A4 inhibition (extrapolated to humans)
• Case series and pharmacovigilance data on EGCG hepatotoxicity (direct signal)
• Case reports of trazodone hepatotoxicity (direct but rare)
• No human pharmacokinetic study on the combination

That evidence profile means the clinical guidance here is reasoned caution, not certainty about harm. A woman who has been drinking green tea with her trazodone for two years and feels well is not in a crisis. A woman who is starting high-dose EGCG capsules for the first time, is perimenopausal, takes trazodone nightly, and has not had liver enzymes checked in years should not wait.

The Natural Medicines Database rates the interaction between green tea and CYP3A4 substrates as "minor to moderate" based on available data. The Drugs.com interaction checker lists a "moderate" interaction between high-dose green tea supplements and trazodone, flagging both the CYP3A4 overlap and the hepatotoxicity concern. Neither database has studied women specifically, or women by hormonal life stage.

Direct quotation from guidance worth knowing: the EFSA Panel on Food Additives and Nutrient Sources stated in 2018: "Catechin intakes of 800 mg/day or above from green tea-based food supplements are associated with a risk of liver damage and are of safety concern." That threshold applies to supplements, not to tea as a beverage.

A second relevant position comes from the European Medicines Agency (EMA), which has reviewed the hepatotoxicity signal for green tea extract and concluded: "Hepatotoxicity caused by green tea preparations containing high concentrations of polyphenols has been observed in humans." This is not a theoretical risk in cell culture models; it has occurred in people using commercial green tea extract products.

Practical substitutes if you want to stop EGCG but keep the benefit

If you are taking green tea extract for its metabolic or antioxidant effects and want to continue supporting those goals while on trazodone, these options carry lower interaction concern:

• Brewed green tea, 2-3 cups daily, providing approximately 150-300 mg total EGCG per day, well below the hepatotoxicity signal threshold
• Dietary sources of polyphenols: berries, dark chocolate, olive oil, vegetables
• For PCOS-related insulin sensitivity: inositol (myo-inositol and D-chiro-inositol), which has RCT evidence in PCOS and does not share the CYP3A4 or hepatotoxic concern
• For perimenopausal metabolic support: discussion with your provider about the evidence base for diet, resistance training, and if appropriate, metformin or GLP-1 therapy

None of these suggestions substitute for individualized clinical advice, and none have the same evidence base as EGCG for every use case. They are alternatives to consider while the conversation with your prescriber happens.